Please use this identifier to cite or link to this item:
Title: SCOTCERV: a phase II trial of docetaxel and gemcitabine as second line chemotherapy in cervical cancer.
Authors: Symonds, RP
Davidson, SE
Chan, S
Reed, NS
McMahon, T
Rai, D
Harden, S
Paul, J
Scottish Gynaecological Cancer Trials Group
Beatson West of Scotland Cancer Centre
First Published: Oct-2011
Citation: GYNECOL ONCOL, 2011, 123 (1), pp. 105-109
Abstract: The aim of the study was to determine the response rate and response duration of cervical cancer previously treated by cisplatin (with or without radiation) to a combination of docetaxel and gemcitabine. Secondary endpoints were assessment of toxicity and quality of life (QoL) of patients receiving the treatment.
DOI Link: 10.1016/j.ygyno.2011.06.001
eISSN: 1095-6859
Type: Journal Article
Appears in Collections:Published Articles, Dept. of Cancer Studies and Molecular Medicine

Files in This Item:
There are no files associated with this item.

Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.